On ECHEMI
Home > Drugs > Hunan Wzt Pharmaceutical Co., Ltd.
Hunan Wzt Pharmaceutical Co., Ltd.
  • Founded in:

    2000-02-29
  • Country:

    China China
  • Address:

    No. 219, Biquantan Road, Tianyi Economic Development Zone, Xiangtan, Hunan Province
  • Tax NO.:

    91430300740629832Q
  • Registered Funds:

    8.08 million yuan
  • Website:

  • Email:

Related Drugs
Lomefloxacin Aspartate Injection
The main ingredient of this product is lomefloxacin aspartate, and its chemical name is: 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid aspartate
Name Description Content CAS NO. Registered Holders
LOMEFLOXACIN, ASPARTATE

Quinolone is a broad-spectrum antibiotic that has bactericidal effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. It has good antibacterial effects on methicillin-resistant Staphylococcus aureus, ampicillin-resistant influenza bacilli, pipemidic acid-resistant Escherichia coli and bacteria resistant to other drugs. Its antibacterial mechanism is to inhibit the activity of bacterial DNA helicase, thereby inhibiting bacterial DNA transcription and replication, and has bactericidal effects on a variety of Gram-positive and Gram-negative bacteria.

More

Quinolone is a broad-spectrum antibiotic that has bactericidal effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. It has good antibacterial effects on methicillin-resistant Staphylococcus aureus, ampicillin-resistant influenza bacilli, pipemidic acid-resistant Escherichia coli and bacteria resistant to other drugs. Its antibacterial mechanism is to inhibit the activity of bacterial DNA helicase, thereby inhibiting bacterial DNA transcription and replication, and has bactericidal effects on a variety of Gram-positive and Gram-negative bacteria.

211690-33-4 7
Lomefloxacin Aspartate Injection
The main ingredient of this product is lomefloxacin aspartate, and its chemical name is: 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid aspartate
Name Description Content CAS NO. Registered Holders
LOMEFLOXACIN, ASPARTATE

Quinolone is a broad-spectrum antibiotic that has bactericidal effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. It has good antibacterial effects on methicillin-resistant Staphylococcus aureus, ampicillin-resistant influenza bacilli, pipemidic acid-resistant Escherichia coli and bacteria resistant to other drugs. Its antibacterial mechanism is to inhibit the activity of bacterial DNA helicase, thereby inhibiting bacterial DNA transcription and replication, and has bactericidal effects on a variety of Gram-positive and Gram-negative bacteria.

More

Quinolone is a broad-spectrum antibiotic that has bactericidal effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. It has good antibacterial effects on methicillin-resistant Staphylococcus aureus, ampicillin-resistant influenza bacilli, pipemidic acid-resistant Escherichia coli and bacteria resistant to other drugs. Its antibacterial mechanism is to inhibit the activity of bacterial DNA helicase, thereby inhibiting bacterial DNA transcription and replication, and has bactericidal effects on a variety of Gram-positive and Gram-negative bacteria.

211690-33-4 7
Calf blood deproteinized extract injection
This product is a sterile aqueous solution containing inorganic substances and small molecular organic substances obtained by deproteinizing, concentrating and ultrafiltration of fresh calf blood.
Name Description Content CAS NO. Registered Holders
Inorganic and small molecule organic substances obtained from fresh calf blood

It can enhance the absorption and utilization of oxygen and glucose by tissue cells, improve the cellular hypoxia state and the internal environment of the body, increase the blood flow of organs such as the heart, brain, and liver, and improve microcirculation

More

It can enhance the absorption and utilization of oxygen and glucose by tissue cells, improve the cellular hypoxia state and the internal environment of the body, increase the blood flow of organs such as the heart, brain, and liver, and improve microcirculation

0
Lidocaine Hydrochloride Injection (Solvent)
The main ingredient of this product is lidocaine hydrochloride. Its chemical name is N-(dichloroxylyl)-2-(diethylamino)acetamide hydrochloride monohydrate.
Name Description Content CAS NO. Registered Holders
Lidocaine hydrochloride

This product is an amide local anesthetic, which has a biphasic effect of excitation and inhibition on the central nervous system. At low doses, it causes analgesia and drowsiness, and increases the pain threshold. At high doses, it has an enhancing effect or toxicity. It has an anticonvulsant effect at sub-toxic concentrations. It has an anti-ventricular arrhythmia effect on the heart and can reduce myocardial autonomy. At therapeutic doses, it has no significant effect on myocardial electrical activity, atrioventricular conduction and contraction. At high concentrations, it slows down the conduction velocity, causes atrioventricular conduction block and inhibits myocardial contractility and cardiac output.

More

This product is an amide local anesthetic, which has a biphasic effect of excitation and inhibition on the central nervous system. At low doses, it causes analgesia and drowsiness, and increases the pain threshold. At high doses, it has an enhancing effect or toxicity. It has an anticonvulsant effect at sub-toxic concentrations. It has an anti-ventricular arrhythmia effect on the heart and can reduce myocardial autonomy. At therapeutic doses, it has no significant effect on myocardial electrical activity, atrioventricular conduction and contraction. At high concentrations, it slows down the conduction velocity, causes atrioventricular conduction block and inhibits myocardial contractility and cardiac output.

6108-05-0 45
Chondroitin Sulfate for Injection
Name Description Content CAS NO. Registered Holders
Chondroitin 4-sulfate

No specific description of pharmacological effects is given from the above information

More

No specific description of pharmacological effects is given from the above information

9007-28-7 2
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.